Metformin Delays Satellite Cell Activation and Maintains Quiescence

The regeneration of the muscle tissue relies on the capacity of the satellite stem cell (SC) population to exit quiescence, divide asymmetrically, proliferate, and differentiate. In age-related muscle atrophy (sarcopenia) and several dystrophies, regeneration cannot compensate for the loss of muscle...

Full description

Saved in:
Bibliographic Details
Main Authors: Theodora Pavlidou, Milica Marinkovic, Marco Rosina, Claudia Fuoco, Simone Vumbaca, Cesare Gargioli, Luisa Castagnoli, Gianni Cesareni
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2019/5980465
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524483103391744
author Theodora Pavlidou
Milica Marinkovic
Marco Rosina
Claudia Fuoco
Simone Vumbaca
Cesare Gargioli
Luisa Castagnoli
Gianni Cesareni
author_facet Theodora Pavlidou
Milica Marinkovic
Marco Rosina
Claudia Fuoco
Simone Vumbaca
Cesare Gargioli
Luisa Castagnoli
Gianni Cesareni
author_sort Theodora Pavlidou
collection DOAJ
description The regeneration of the muscle tissue relies on the capacity of the satellite stem cell (SC) population to exit quiescence, divide asymmetrically, proliferate, and differentiate. In age-related muscle atrophy (sarcopenia) and several dystrophies, regeneration cannot compensate for the loss of muscle tissue. These disorders are associated with the depletion of the satellite cell pool or with the loss of satellite cell functionality. Recently, the establishment and maintenance of quiescence in satellite cells have been linked to their metabolic state. In this work, we aimed to modulate metabolism in order to preserve the satellite cell pool. We made use of metformin, a calorie restriction mimicking drug, to ask whether metformin has an effect on quiescence, proliferation, and differentiation of satellite cells. We report that satellite cells, when treated with metformin in vitro, ex vivo, or in vivo, delay activation, Pax7 downregulation, and terminal myogenic differentiation. We correlate the metformin-induced delay in satellite cell activation with the inhibition of the ribosome protein RPS6, one of the downstream effectors of the mTOR pathway. Moreover, in vivo administration of metformin induces a belated regeneration of cardiotoxin- (CTX-) damaged skeletal muscle. Interestingly, satellite cells treated with metformin immediately after isolation are smaller in size and exhibit reduced pyronin Y levels, which suggests that metformin-treated satellite cells are transcriptionally less active. Thus, our study suggests that metformin delays satellite cell activation and differentiation by favoring a quiescent, low metabolic state.
format Article
id doaj-art-ba82ec80978a4a07b80052def2cc3deb
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-ba82ec80978a4a07b80052def2cc3deb2025-02-03T05:53:03ZengWileyStem Cells International1687-966X1687-96782019-01-01201910.1155/2019/59804655980465Metformin Delays Satellite Cell Activation and Maintains QuiescenceTheodora Pavlidou0Milica Marinkovic1Marco Rosina2Claudia Fuoco3Simone Vumbaca4Cesare Gargioli5Luisa Castagnoli6Gianni Cesareni7Department of Biology, Tor Vergata University, 00133 Rome, ItalyDepartment of Biology, Tor Vergata University, 00133 Rome, ItalyDepartment of Biology, Tor Vergata University, 00133 Rome, ItalyDepartment of Biology, Tor Vergata University, 00133 Rome, ItalyDepartment of Biology, Tor Vergata University, 00133 Rome, ItalyDepartment of Biology, Tor Vergata University, 00133 Rome, ItalyDepartment of Biology, Tor Vergata University, 00133 Rome, ItalyDepartment of Biology, Tor Vergata University, 00133 Rome, ItalyThe regeneration of the muscle tissue relies on the capacity of the satellite stem cell (SC) population to exit quiescence, divide asymmetrically, proliferate, and differentiate. In age-related muscle atrophy (sarcopenia) and several dystrophies, regeneration cannot compensate for the loss of muscle tissue. These disorders are associated with the depletion of the satellite cell pool or with the loss of satellite cell functionality. Recently, the establishment and maintenance of quiescence in satellite cells have been linked to their metabolic state. In this work, we aimed to modulate metabolism in order to preserve the satellite cell pool. We made use of metformin, a calorie restriction mimicking drug, to ask whether metformin has an effect on quiescence, proliferation, and differentiation of satellite cells. We report that satellite cells, when treated with metformin in vitro, ex vivo, or in vivo, delay activation, Pax7 downregulation, and terminal myogenic differentiation. We correlate the metformin-induced delay in satellite cell activation with the inhibition of the ribosome protein RPS6, one of the downstream effectors of the mTOR pathway. Moreover, in vivo administration of metformin induces a belated regeneration of cardiotoxin- (CTX-) damaged skeletal muscle. Interestingly, satellite cells treated with metformin immediately after isolation are smaller in size and exhibit reduced pyronin Y levels, which suggests that metformin-treated satellite cells are transcriptionally less active. Thus, our study suggests that metformin delays satellite cell activation and differentiation by favoring a quiescent, low metabolic state.http://dx.doi.org/10.1155/2019/5980465
spellingShingle Theodora Pavlidou
Milica Marinkovic
Marco Rosina
Claudia Fuoco
Simone Vumbaca
Cesare Gargioli
Luisa Castagnoli
Gianni Cesareni
Metformin Delays Satellite Cell Activation and Maintains Quiescence
Stem Cells International
title Metformin Delays Satellite Cell Activation and Maintains Quiescence
title_full Metformin Delays Satellite Cell Activation and Maintains Quiescence
title_fullStr Metformin Delays Satellite Cell Activation and Maintains Quiescence
title_full_unstemmed Metformin Delays Satellite Cell Activation and Maintains Quiescence
title_short Metformin Delays Satellite Cell Activation and Maintains Quiescence
title_sort metformin delays satellite cell activation and maintains quiescence
url http://dx.doi.org/10.1155/2019/5980465
work_keys_str_mv AT theodorapavlidou metformindelayssatellitecellactivationandmaintainsquiescence
AT milicamarinkovic metformindelayssatellitecellactivationandmaintainsquiescence
AT marcorosina metformindelayssatellitecellactivationandmaintainsquiescence
AT claudiafuoco metformindelayssatellitecellactivationandmaintainsquiescence
AT simonevumbaca metformindelayssatellitecellactivationandmaintainsquiescence
AT cesaregargioli metformindelayssatellitecellactivationandmaintainsquiescence
AT luisacastagnoli metformindelayssatellitecellactivationandmaintainsquiescence
AT giannicesareni metformindelayssatellitecellactivationandmaintainsquiescence